The V.A.Cure Consortium consists of 7 academic laboratories and 2 companies-AstraZeneca from Sweden and Finnadvance from Finland.

Via secondments, students will perform their research in several laboratories in Europe.Thus, during their PhD programme, PhD students will gain experience in academia and the private sector.

V.A.Cure project is supported by 9 partner organisations across Europe (5 companies, two universities, one hospital and a patient organization).

Partner organisations will contribute to the quality and diversity of secondments and education programme of selected PhD candidates.